Catabasis Pharmaceuticals Price Prediction
At the present time the value of rsi of Catabasis Pharmaceuticals' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.
The successful prediction of Catabasis Pharmaceuticals' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Catabasis Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Catabasis Pharmaceuticals hype-based prediction, you can estimate the value of Catabasis Pharmaceuticals from the perspective of Catabasis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Catabasis Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Catabasis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Catabasis Pharmaceuticals after-hype prediction price | USD 0.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Catabasis |
| Symbol | CATB |
| Name | Catabasis Pharmaceuticals |
| Type | Stock |
| Country | United States |
| Exchange | NASDAQ |
Hype Analysis is not found for Catabasis Pharmaceuticals at this timeWe are unable to locate Catabasis Pharmaceuticals hype analysis at this time. If you believe the equity you are trying to look up is valid, please let us know, and we will check it out.Hype Analysis
Prediction analysis is currently not available
Other Suggestions
| CA | Xtrackers California Municipal | ETF |
| CADE-PA | Cadence Bank | Company |
| CAC | Camden National | Company |
| CAF | Morgan Stanley China | Fund |
Thematic Opportunities
Explore Investment Opportunities
Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Catabasis Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Catabasis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Catabasis using various technical indicators. When you analyze Catabasis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Story Coverage note for Catabasis Pharmaceuticals
The number of cover stories for Catabasis Pharmaceuticals depends on current market conditions and Catabasis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Catabasis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Catabasis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Catabasis Pharmaceuticals Short Properties
Catabasis Pharmaceuticals' future price predictability will typically decrease when Catabasis Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Catabasis Pharmaceuticals often depends not only on the future outlook of the potential Catabasis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Catabasis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Shares Percent Shares Out | 0.75% | |
| Short Percent Of Float | 0.78% | |
| Float Shares | 7.3M | |
| Shares Short Prior Month | 441.8k | |
| Average Daily Volume Last 10 Day | 98.5k | |
| Average Daily Volume In Three Month | 289.34k | |
| Date Short Interest | 30th of July 2021 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Catabasis Stock
If you are still planning to invest in Catabasis Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catabasis Pharmaceuticals' history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |